LataMed AI Corp. (CCTC) invokes Rule 12b-25, expects 5-day 10-Q extension

Rhea-AI Filing Summary

LataMed AI Corp. notified the SEC that it cannot file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 within the prescribed time and expects to file within the five-calendar-day extension permitted by Rule 12b-25. The notification was signed by CEO Kevin Rodan Levy on May 15, 2026.

Insights

SEC Filings Analyst

Routine late-filing notice invoking Rule 12b-25; short extension expected.

The company filed a Notification of Late Filing (Form 12b-25) stating it cannot timely file its Form 10-Q for the period ended March 31, 2026 and expects to use the five-calendar-day extension under Rule 12b-25. This is a procedural disclosure, not a restatement or admission of substantive error.

Cash-flow or operational impacts are not described; the filing affirms other periodic reports are current and does not state any anticipated significant change in results. Subsequent filings will show whether the extension was sufficient.

Key Figures

Commission File Number: 000-56634 Quarter end: March 31, 2026 Notification date: May 15, 2026 +2 more

5 metrics

Commission File Number 000-56634 cover line of the Form 12b-25

Quarter end March 31, 2026 period for the delayed Form 10-Q

Notification date May 15, 2026 date the Form 12b-25 was signed by CEO Kevin Rodan Levy

Extension length five calendar days extension period permitted under Rule 12b-25 for a quarterly report

Telephone (787) 476-2350 registrant contact listed in the filing

Key Terms

Rule 12b-25, Form 10-Q, Notification of Late Filing (Form 12b-25)

3 terms

Rule 12b-25 regulatory

"expects to file the Quarterly Report within the extension period of five calendar days permitted under Rule 12b-25"

Rule 12b-25 is an SEC filing provision that lets a company notify regulators and the public that it cannot file a required periodic report (like a quarterly or annual report) on time and explains the reason for the delay. For investors, the notice is a formal heads-up that financial information will arrive late—similar to a company calling to say it will be late turning in homework—so it signals increased uncertainty and may affect trading and risk assessments until the filing is available.

Form 10-Q regulatory

"unable to file its Quarterly Report on Form 10-Q for the period ended March 31, 2026"

A Form 10-Q is a detailed report that publicly traded companies are required to file with regulators three times a year, providing an update on their financial health and business activities. It is important for investors because it offers timely insights into a company's performance, helping them make informed decisions about buying or selling stocks. Think of it as a regular check-up report that shows how well a company is doing.

Notification of Late Filing (Form 12b-25) regulatory

"FORM 12b-25 NOTIFICATION OF LATE FILING For Period Ended: March 31, 2026"

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 12b-25

Commission File Number: 000-56634

NOTIFICATION OF LATE FILING

☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR

For Period Ended: March 31, 2026

	☐	Transition Report on Form 10-K
	☐	Transition Report on Form 10-Q
	☐	Transition Report on Form 20-F
	☐	Transition Report on Form 11-K
	☐	Transition Report on Form N-SAR
	For the Transition Period Ended: _______________________________________

Nothing in this form shall be construed to imply that the Commission

has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:  

PART I

REGISTRANT INFORMATION

Full name of registrant	LataMed AI Corp.
Former name if applicable
Address of principal executive office	Av. Rómulo Gallegos con Av. Las Palmas Edif. Torre Gerencial Los Andes, Piso 4
City, state and zip code	Caracas 1071, Venezuela

PART II

RULE 12b-25 (b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25 (b), the following should be completed. (Check box if appropriate.)

	(a)	The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
☒	(b)	The subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K or Form N-SAR or Form N-CSR, or portion thereof will be filed on or before the 15th calendar day following the prescribed due date or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the 5th calendar day following the prescribed due date; and
	(c)	The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III

NARRATIVE

State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q, N-SAR, N-CSR, or the transition report portion thereof, could not be filed within the prescribed time period.

LataMed AI Corp. (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Quarterly Report”) within the prescribed time period without unreasonable effort and expense. The Company currently expects to file the Quarterly Report within the extension period of five calendar days permitted under Rule 12b-25 of the Securities Exchange Act of 1934, as amended.

PART IV

OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

Kevin Rodan Levy		(787)		476-2350
(Name)		(Area Code)		(Telephone Number)

(2)	Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
	☒ Yes     ☐ No
(3)	Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
	☐ Yes     ☒ No

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. 

2

LataMed AI Corp.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: May 15, 2026	By:	/s/ Kevin Rodan Levy
	Name:	Kevin Rodan Levy
	Title:	Chief Executive Officer

3

FAQ

Why did LataMed AI Corp. (CCTC) file a Form 12b-25?

LataMed AI filed Form 12b-25 to notify the SEC it cannot timely file its Form 10-Q for the period ended March 31, 2026. The company states it will use the five-calendar-day extension permitted under Rule 12b-25 and expects to file within that period.

When does LataMed AI expect to file the delayed 10-Q?

The company expects to file the Quarterly Report within the five-calendar-day extension under Rule 12b-25. The notification itself is dated May 15, 2026, which anchors the extension period from the prescribed due date.

Does the 12b-25 notice say there will be material changes to results?

No. The form asks if a significant change in results is anticipated; the company checked No. The filing does not attach any narrative or quantitative estimate of material changes to operating results.

Has LataMed AI filed other required periodic reports in the last 12 months?

The company answered Yes to having filed all other required periodic reports during the preceding 12 months. The 12b-25 notice therefore applies only to the current 10-Q for the quarter ended March 31, 2026.